1 (tie), A Lim Kim, Hyo Joo Kim, Cheyenne Knight, Lydia Ko and Nelly Korda, 1.00%. 6 (tie), Celine Boutier, Ayaka Furue, Jin Young Ko and Patty Tavatanakit, .67%. 10, Hannah Green, .60%. 1 (tie), ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its fourth quarter and full year 2024 ...

A quirk in the website OpenSecrets has given RFK Jr. a chance to misleadingly portray Sen. Bernie Sanders as receiving big ...

Roche, Novartis, Johnson & Johnson Innovative Medicine, Takeda, SHL Medical, Nestlé, Lindt & Sprüngli, Givaudan, Schneider Electric, Schindler, Endress+Hauser Flowtec, VAT Group and SFS Group. They ...

In February 2024, the government slashed GST (Goods and Services Tax) from three major cancer drugs: Trastuzumab Deruxtecan, ...

A Feature on M&A, VC investment licensing and partnerships focusing on novel targets in autoimmune diseases. The global ...

The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...

As we move forward, the BMC remains dedicated to its mission of elevating industry-wide excellence in biospecimen management, raising the bar for data integrity and quality, enabling the future of ...

Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets ...

The global enzyme replacement therapy market size was valued at USD 10.12 billion in 2024 and is projected to grow from USD 11.35 billion in 2025 to reach USD 21.29 billion by 2033, exhibiting a CAGR ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Personalized medicine advances as autologous cell therapy grows, leveraging refined cell collection, improved processing ...